{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:37:06Z","timestamp":1767969426883,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.clinbiochem.2012.12.007","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T18:51:04Z","timestamp":1355943064000},"page":"698-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasma S100\u03b2 is not a useful biomarker for tumor burden in neurofibromatosis"],"prefix":"10.1016","volume":"46","author":[{"given":"Miriam J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Esparza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa L.","family":"Merker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alona","family":"Muzikansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam A.","family":"Bredella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon J.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ara","family":"Kassarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor F.","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cncr.21220","article-title":"S100beta as a predictor of brain metastases: brain versus cerebrovascular damage","volume":"104","author":"Vogelbaum","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0010","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/neu.2008.0738","article-title":"Validation of serum markers for blood\u2013brain barrier disruption in traumatic brain injury","volume":"26","author":"Blyth","year":"2009","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0015","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1245\/s10434-009-0629-8","article-title":"S-100B concentrations predict disease-free survival in stage III melanoma patients","volume":"16","author":"Kruijff","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0020","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/cncr.11409","article-title":"Serum S100beta: a noninvasive marker of blood\u2013brain barrier function and brain lesions","volume":"97","author":"Kanner","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0025","doi-asserted-by":"crossref","first-page":"e35711","DOI":"10.1371\/journal.pone.0035711","article-title":"Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis","volume":"7","author":"Plotkin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0030","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/clinchem\/48.6.950","article-title":"The serum S100B concentration is age dependent","volume":"48","author":"Portela","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0035","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/088307380201700802","article-title":"Neurofibromatosis 1: clinical manifestations and diagnostic criteria","volume":"17","author":"Friedman","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0040","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jmg.2004.029504","article-title":"The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2","volume":"42","author":"Baser","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0045","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1158\/1078-0432.CCR-10-0613","article-title":"Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin","volume":"16","author":"Hummel","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/emmm.200900027","article-title":"Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene","volume":"1","author":"Miller","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.clinbiochem.2012.12.007_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1741-7015-9-82","article-title":"MIA is a potential biomarker for tumour load in neurofibromatosis type 1","volume":"9","author":"Kolanczyk","year":"2011","journal-title":"BMC Med"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012006959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012006959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:40:23Z","timestamp":1757864423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012006959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":11,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0009912012006959"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.12.007","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma S100\u03b2 is not a useful biomarker for tumor burden in neurofibromatosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}